Clinical trial reportThe Lancet. OncologyPublished
Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial
13 of 32 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- The Lancet. Oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Thalidomide; Dexamethasone; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Drug Resistance, Neoplasm; Adult; Aged; Middle Aged; Female; Male
- PubMed ID
- 41519141
- Added to directory
- Source checked